University of Adelaide, Adelaide, Australia.
J Psychopharmacol. 2010 Dec;24(12):1834-6. doi: 10.1177/0269881109358202. Epub 2010 Feb 8.
The challenges in the management of treatment-resistant rapid-cycling bipolar disorder are multifaceted and represent a significant burden to the patient. There is a need for more exploration into the potential utility of various combination therapies in the setting of severe affective states. A 52-year-old woman with a history of severe treatment-resistant rapid-cycling bipolar affective disorder (BPAD) was hospitalized for the treatment of a severe mixed episode. The introduction of lamotrigine and clozapine in combination proved remarkably effective and well tolerated in both the acute management and in subsequent maintenance. The patient has remained asymptomatic during the 5-year follow-up without any further mood disturbance. Lamotrigine and clozapine are among the less-prescribed agents for BPAD and there is as yet little research into their use in combination. It is possible that these agents have complementary modes of action on various facets of the affective pathology, resulting in superior mood stabilization in this patient.
治疗抵抗性快速循环双相情感障碍的管理面临诸多挑战,给患者带来了巨大负担。在严重情感状态下,需要进一步探索各种联合治疗的潜在效用。
一位 52 岁女性,患有严重的治疗抵抗性快速循环双相情感障碍(BPAD),因严重混合发作而住院治疗。拉莫三嗪和氯氮平联合使用在急性治疗和随后的维持治疗中均表现出显著疗效且耐受性良好。在 5 年的随访中,患者无症状,无任何进一步的情绪障碍。拉莫三嗪和氯氮平是 BPAD 较少开处方的药物之一,目前关于它们联合使用的研究很少。这些药物可能对情感病理学的各个方面具有互补的作用机制,从而使该患者的情绪稳定效果更好。